American Well shares rise 158% YTD, poised for growth with new government contracts and positive cash flow by 2026

American Well Corporation's shares have surged 158% year-to-date but still trade at a low forward price-to-sales ratio of 1x. The company expects significant revenue and EBITDA growth by 2027, driven by upcoming Department of Health and Human Services (DHA) and Veterans Affairs (VA) government contracts. Despite current revenue declines, American Well projects positive EBITDA and operating cash flow by the fourth quarter of 2026, supported by cost-cutting measures and platform expansion. The company's strong balance sheet, with $196 million in cash and no debt, underpins its undervalued status compared to the sector.

American Well Corp trades at USD 12.56 on Pluang as of Oct 08, 2026 23:03 WIB, with a market cap of $214.99 million and a slight 1-day decline of 0.63%. The stock remains close to its 52-week high of $13.87, reflecting sustained investor interest despite recent revenue challenges noted in the news. Pluang users show balanced sentiment with 54% buy and 46% sell orders, indicating cautious optimism ahead of the company’s expected growth from government contracts.